Trial Profile
An Open Label, Single Center, Nonrandomized Continuation Study of Cholic Acid Capsules to Treat Subjects With Inborn Errors of Bile Acid Synthesis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Oct 2023
Price :
$35
*
At a glance
- Drugs Cholic acid (Primary)
- Indications Inborn genetic disorders; Zellweger syndrome
- Focus Therapeutic Use
- Sponsors Mirum Pharmaceuticals; Travere Therapeutics
- 15 Aug 2016 Status changed from active, no longer recruiting to completed.
- 26 Oct 2015 Planned End Date changed from 1 Jun 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.
- 26 Oct 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.